115 results on '"Aiba, Setsuya"'
Search Results
2. Cohort study of subclinical sensitization against galactose‐α‐1,3‐galactose in Japan: Prevalence and regional variations
3. Characterization of rosacea patients in Tohoku area of Japan: Retrospective study of 340 rosacea cases
4. Ehlers–Danlos syndrome type IV with a novel COL3A1 exon 14 skipping variation confirmed by Tohoku Medical Megabank Organization genomic database
5. Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients
6. Body mass index, HbA1c and serum C‐reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital‐based retrospective case‐control study
7. 2020 guidelines for the diagnosis and treatment of prurigo
8. 2020 guidelines for the diagnosis and treatment of cutaneous pruritus
9. Successful treatment of BRAF/MEK inhibitor‐resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity‐modulated radiotherapy
10. Chronological changes of skin eruptions toward cold abscess formation in hyper‐immunoglobulin E syndrome
11. Pediatric psoriasis induced by HLA‐B46‐Cw1 haplotype: A retrospective study of psoriasis onset after hematopoietic stem cell transplantation
12. Non‐immunoglobulin G4‐related multifocal fibrosclerosis presenting generalized morphea‐like skin lesions
13. Efficacy and safety of i.v. methylprednisolone pulse therapy for vitiligo: A retrospective study of 58 therapy experiences for 33 vitiligo patients
14. RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma
15. Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial
16. Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma
17. Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid
18. Case series of BRAF ‐mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy
19. Multiple halo nevi associated with Turner syndrome
20. Severe eczematoid and lichenoid eruption with full‐thickness epidermal necrosis developing from metastatic urothelial cancer treated with enfortumab vedotin
21. Scalp lymphangiosarcoma: A distinct skin manifestation of edematous erythema on face and scalp without subcutaneous hemorrhage or preceding condition of lymphedema
22. Short anagen syndrome: A unique short hair syndrome without any characteristic hair morphological abnormality
23. Psoriatic arthritis with skin lesions localized to the scalp: A case report
24. Severe pyrexia from nivolumab‐resistant advanced melanoma after successful combined therapy with encorafenib plus binimetinib
25. Case series of cutaneous T‐cell lymphomas treated with bexarotene‐based therapy
26. Fixed erythrodysaesthesia plaque on the neck near indwelling subcutaneous port and catheter due to vinorelbine and cisplatin treatment
27. Atopic dermatitis without serum immunoglobulin E elevation or loss‐of‐function filaggrin gene mutation in a patient with X‐linked agammaglobulinemia
28. Case of morphea with symmetrical distribution of sclerotic lesions on bilateral forearms accompanied by extensive nail fold capillary abnormalities in multiple fingers
29. Rare manifestation of hypereosinophilic syndrome: Diffuse‐type hair loss with massive perifollicular eosinophils
30. Subcutaneous granulomatous reaction with eosinophil infiltration to a silicone continuous ambulatory peritoneal dialysis Tenckhoff catheter
31. A novel technique to diagnose non‐melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors
32. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases
33. Malassezia ‐derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra‐mammary Paget's disease
34. Lichen planus pemphigoides developing from patient with non‐small‐cell lung cancer treated with nivolumab
35. Successful treatment of multiple eruptive adult xanthogranuloma concomitant with xanthelasma palpebrarum with probucol
36. Three cases of nivolumab therapy‐failed advanced melanoma successfully controlled by ipilimumab with intensity‐modulated radiotherapy
37. Successful treatment of unresectable recurrent programmed death ligand 1 moderately‐expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy
38. Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S‐1 monotherapy
39. Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy
40. Eruptive keratoacanthoma with spontaneous regression arising from a cervical squamous cell carcinoma patient treated with nivolumab
41. Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs
42. Edible oil methods to remove asphalt on burns
43. Two cases of dabrafenib and trametinib therapy-failed advanced melanoma successfully controlled by nivolumab monotherapy
44. Toll‐like receptors 2 and 3 enhance melanogenesis and melanosome transport in human melanocytes
45. HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy
46. Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: A blinded randomized clinical trial
47. Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable
48. Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages
49. Successful treatment of relapsed folliculotropic mycosis fungoides with mogamulizumab followed by intensity-modulated radiotherapy
50. Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.